Common Contracts
6 similar Warrant Agreement contracts by BioScrip, Inc., Ares Management LLC, Coliseum Capital Management, LLC
FORM OF AMENDED AND RESTATED WARRANT AGREEMENTWarrant Agreement • March 15th, 2019 • Ares Management LLC • Services-home health care services • Delaware
AMENDED AND RESTATED WARRANT AGREEMENT, dated as March 14, 2019, among BioScrip, Inc., a Delaware corporation (together with its successors and assigns, the “Company”) and the holders undersigned hereto (collectively and together with each of their respective successors and assigns, the “Holders”). Capitalized terms shall have the meaning specified in Section 5.1 hereof.
BIOSCRIP, INC. FORM OF AMENDED AND RESTATED WARRANT AGREEMENT Dated As Of March 14, 2019 Warrants to Purchase shares of Common Stock BIOSCRIP, INC. Amended and Restated Warrant Agreement Warrants For Common StockWarrant Agreement • March 15th, 2019 • BioScrip, Inc. • Services-home health care services • Delaware
AMENDED AND RESTATED WARRANT AGREEMENT, dated as March 14, 2019, among BioScrip, Inc., a Delaware corporation (together with its successors and assigns, the “Company”) and the holders undersigned hereto (collectively and together with each of their respective successors and assigns, the “Holders”). Capitalized terms shall have the meaning specified in Section 5.1 hereof.
BIOSCRIP, INC. 1600 Broadway, Suite 700 Denver, CO 80202 March 14, 2019Warrant Agreement • March 15th, 2019 • Ares Management LLC • Services-home health care services • Delaware
Reference is made to (i) that certain Warrant Agreement (the “Warrant Agreement”), dated June 29, 2017, by and among BioScrip, Inc., a Delaware corporation (the “Company”) and the purchasers signatory thereto (collectively with their successors and assigns, the “Original Purchasers”); (ii) that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of the date hereof, by and among the Company, HC Group Holdings I, LLC (“Omega Parent”), HC Group Holdings II, Inc., Beta Sub, Inc., Beta Sub, LLC and HC Group Holdings III, Inc.; and (iii) that certain Amended and Restated Warrant Agreement, dated as of the date hereof, by and among the Company and the Holder and other Holders party thereto (the “Warrant Amendment”), attached hereto as Exhibit B. This letter agreement (this “Letter Agreement”) confirms certain agreements and understandings between the Holder and the Company related to the Warrant Amendment (as defined below).
BIOSCRIP, INC. WARRANT AGREEMENT Dated As Of June 29, 2017 Warrants to Purchase shares of Common Stock BIOSCRIP, INC. Warrant Agreement Warrants For Common StockWarrant Agreement • June 29th, 2017 • BioScrip, Inc. • Services-home health care services • Delaware
WARRANT AGREEMENT, dated as of June 29, 2017, among BioScrip, Inc., a Delaware corporation (together with its successors and assigns, the “Company”) and the purchasers undersigned hereto (collectively and together with each of their respective successors and assigns, the “Purchasers”). Capitalized terms shall have the meaning specified in Section 5.1 hereof.
BIOSCRIP, INC. WARRANT AGREEMENT DATED AS OF MARCH 9, 2015 WARRANTS TO PURCHASE 3,600,000 SHARES OF COMMON STOCKWarrant Agreement • March 19th, 2015 • Coliseum Capital Management, LLC • Retail-drug stores and proprietary stores • Delaware
WARRANT AGREEMENT, dated as of March 9, 2015, among BioScrip, Inc., a Delaware corporation (together with its successors and assigns, the “Company”), Coliseum Capital Partners, L.P., a Delaware limited partnership, Coliseum Capital Partners II, L.P., a Delaware limited partnership, and Blackwell Partners, LLC, Series A, a Georgia limited liability company (collectively and together with each of their respective successors and assigns, the “Purchasers”). Capitalized terms shall have the meaning specified in Section 5.1 hereof.
BIOSCRIP, INC. WARRANT AGREEMENT Dated As Of March 9, 2015 Warrants to Purchase 3,600,000 shares of Common StockWarrant Agreement • March 10th, 2015 • BioScrip, Inc. • Retail-drug stores and proprietary stores • Delaware
WARRANT AGREEMENT, dated as of March 9, 2015, among BioScrip, Inc., a Delaware corporation (together with its successors and assigns, the “Company”), Coliseum Capital Partners, L.P., a Delaware limited partnership, Coliseum Capital Partners II, L.P., a Delaware limited partnership, and Blackwell Partners, LLC, Series A, a Georgia limited liability company (collectively and together with each of their respective successors and assigns, the “Purchasers”). Capitalized terms shall have the meaning specified in Section 5.1 hereof.
